Durham.

PositionTriangle - Brief article

DURHAM -- Gilead Sciences will close its local operation by the end of the year, laying off about 150. Most of its work here involved developing treatments for hepatitis B and C. It will move that research to its headquarters in Forest City, Calif.

For a daily roundup...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT